Liquidia Corp
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
Mailing Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
Phone
919.328.4400
Fiscal Year End
1231
EIN
851710962
Financial Overview
FY2025
$327.93M
Total Assets
$283.19M
Total Liabilities
$190.68M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 16, 2026 | View on SEC |
| 4 Insider stock transaction report | April 16, 2026 | View on SEC |
| 4 Insider stock transaction report | April 14, 2026 | View on SEC |
| 4 Insider stock transaction report | April 14, 2026 | View on SEC |
| 4 Insider stock transaction report | April 14, 2026 | View on SEC |
| 4 Insider stock transaction report | April 14, 2026 | View on SEC |
| 4 Insider stock transaction report | April 14, 2026 | View on SEC |
| 4 Insider stock transaction report | April 14, 2026 | View on SEC |
| 4 Insider stock transaction report | April 14, 2026 | View on SEC |
| 4 Insider stock transaction report | April 14, 2026 | View on SEC |
Annual Reports
10-K
March 5, 2026
- Liquidia's core focus is on YUTREPIA (treprostinil) inhalation powder for Pulmonary Arterial Hypertension (PAH), utilizing its proprietary PRINT® technology.
- The company maintains a strong cash position of approximately $140 million as of December 31, 2025, crucial for ongoing operations and development.
Insider Trading
STRONG SELL
10 insiders
46 recent transactions
View Insider Trading Dashboard
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.